OLY
Olympus ADR
Stock
Stock
ISIN: US68163W2089
Ticker: OLYMY
US68163W2089
OLYMY
Price
Price
CHART BY
Frequently asked questions
What is Olympus ADR's market capitalization?
The market capitalization of Olympus ADR is $90.69M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Olympus ADR's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Olympus ADR is 18.06. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Olympus ADR?
Olympus ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.004449. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Olympus ADR's stock?
Currently, 12 analysts cover Olympus ADR's stock, with a consensus target price of $0.0894. Analyst ratings provide insights into the stock's expected performance.
What is Olympus ADR's revenue over the trailing twelve months?
Over the trailing twelve months, Olympus ADR reported a revenue of $43.99M.
What is the EBITDA for Olympus ADR?
Olympus ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $10.36M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Olympus ADR?
Olympus ADR has a free cash flow of $4.45M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Olympus ADR have, and what sector and industry does it belong to?
Olympus ADR employs approximately 29,297 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
Financials
- Market Cap
- $90.69M
- EPS (TTM)
- 0.004449
- P/E ratio (TTM)
- 18.06
- Revenue (TTM)
- $43.99M
- EBITDA (TTM)
- $10.36M
- Free Cashflow (TTM)
- $4.45M
Analyst Ratings
The price target is $0.0894 and the stock is covered by 12 analysts.
Buy
4
Hold
8
Sell
0
Information
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Endoscope Business and Therapeutic Equipment Business. The Endoscope Business segment develops and sells medical endoscopes and imaging systems for minimally invasive diagnostics. The Therapeutic Equipment Business segment provides medical devices and systems used in surgical and therapeutic procedures across various specialties. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
- Employees
- 29,297
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US68163W2089
- Primary Ticker
- OLYMY
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet